“…That study suggested that relative deficiency of these acceptor proteins may be rate limiting in a transfer process. More recently, ligandinaemia has been reported in a number of inflammatory and neoplastic liver diseases, including viral and chronic hepatitis, cirrhosis and primary hepatocarcinoma [4][5][6][7]. These observations have prompted the suggestion that ligandinaemia may well provide a further means of evaluating liver damage and be of diagnostic value in cases of primary liver cell cancer [8,9].…”